Genetics of mucopolysaccharidoses
https://doi.org/10.25789/YMJ.2022.78.26
Abstract
The article presents a review of the literature on the clinical picture and diagnosis of mucopolysaccharidosis (MPS) using the PubMed database, eLIBRARY.RU, Google Academia
About the Authors
S. N. NovgorodovaRussian Federation
junior researcher
N. R. Maksimova
Russian Federation
Doctor of Medical Science, Chief Researcher - Head
A. L. Sukhomyasova
Russian Federation
Ph.D. of Medical Sciences, Leading Researcher - Deputy Head
References
1. Krasnopolskaya E.Y., Voskoboeva E.Y. [et al.] Identification of mutations in the aryl sulfatase gene in Russian patients with mucopolysaccharidosis type VI. Genetics. 2000; 6: 837-843.
2. Zakharova E.Yu., Baydakova G.V., Mikhailova S.V. [et al.]. Lysosomal accumulation diseases. Pediatrics and pediatric surgery. 2010; 4: 49-53.
3. Voinova V.Yu., Semyachkina A.N., Voskoboeva E.Yu. [et al.] Mucopolysaccharidosis type VI (Maroto-Lami syndrome): Clinical manifestations, diagnosis and treatment. Russian Bulletin of Perinatology and Pediatrics. 2014; 4: 2-23.
4. Moiseev S.V., Novikov P.I. [et al.]. Mucopolysaccharidosis type VI in adults. Clinical pharmacology and therapy. 2011; 1: 72-79.
5. Mikhailova L.K., Polyakova O.A. [et al.] Late diagnosis of mucopolysaccharidosis type VI (Maroto—Lami syndrome). Bulletin of Traumatology and Orthopedics named after N.N. Priorov. 2017; 3: 51-55
6. A clinical study of 77 patients with mucopolysaccharidosis type II / I. V. Schwartz, M. G Ribeiro [et al.] // Acta Paediatr. Suppl. 2007; 96: 63 – 70.
7. Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA / R. K. Rumsey, K. Rudser, E. Shapiro [et al.] // J. Pediatr. 2014; 164 (5): 1147 – 1151.
8. Aortic valve replacement in a patient with Morquio syndrome / F. Nicolini, D. Corradi [et al.] // Heart. Surg. Forum. 2008;11: 96 - 98.
9. Barranger J. A. Lysosomal storage disorder / J. A. Barranger, M. A. Cabrera-Salazar// Berlin: Springer. 2007; 574.
10. Cardiovascularmanifestations of the Hurler syndrome. Hemodynamic and angiocardiographic observations in 15 patient / L. J. Krovetz, A. E. Lorincz [et al.] // Irculation. 1965; 31: 132 - 141.
11. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA / C.J. Hendriksz, M. Al-Jawad [et al.]// J. Inheri.t Metab. Dis. 2013; 36: 309 - 320.
12. Clinical, biochemical, and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome / M. A. Chiong, D. Canon [et al.] // Orphanet J. Rare Dis. 2017; 12: 7.
13. Chen M. R. Cardiovascular changesin Mucopolysaccharidosis / M. R. Chen, S. P. Lin // Taiwan. Acta Cardiol. 2005; 60: 51 - 53.
14. Cumulative incidence rates of the mucopolysaccharidoses in Germany / F. Baehner, C. Schmiedeskamp [et al.]// Inherit. Metab. Dis. 2005; 28(6): 1011 - 1017.
15. Evaluation of disease severity in Mucopolysaccharidosis / M. Beck, J. Muenzer [et al.]// J. Pediatr. Rehab. Med. 2010; 3 (1): 39-46.
16. Hunter C. A. Rare disease in two brothers / C. A. Hunter // Proc. R. Soc. Med. 1917; 10: 104 - 116.
17. Imundo L. A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis //Journal of inherited metabolic disease. 2011; 34 (5): 1013-1022.
18. Incidence of the mucopolysaccharidoses in Western Australia / J. Nelson, J. Crowhurst [et al.] // Am. J. Med. Genet. A. 2003; 123: 310 - 313.
19. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence / G. Malm, A. M. Lund [et al.] // Acta Paediatr. 2008; 97: 1577 -1581.
20. Mucopolysaccharidosis Type IIIA presents as a variant of Kluver–Bucy syndrome / M. Potegal, B. Yund [et al.] // J. Clin. Exp. Neuropsychol. 2013; 35 (6): 608 - 616.
21. Mucopolysaccharidosis VI / V. Valayannopoulos, H. Nicely [et al.]// Orphanet J. Rare Dis. 2010; 5: 5.
22. Mutation in VPS33A affects metabolism of glycosaminoglycans: a new type of mucopolysaccharidosis with severe systemic symptoms / H. Kondo, N.R. Maksimova [et al.] //Human Molecular Genetics. 2017; 26 (1): 173-183.
23. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA / C. J. Hendriksz, P Harmatz [et al.] // Mol. Genet. Metab. 2013; 110: 54 – 64.
24. Respiratory manifestations in Mucopolysaccharidosis / M. S. Muhlebach, W. Wooten [et al.] // Paediatr. Respir. Rev. 2011; 12: 133 - 138.
25. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome) / R. Martin, M. Beck [et al.]// Pediatrics. 2008; 121 (2): 377 - 386.
26. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A) / A. Meyer, K. Kossow [et al.]// Pediatrics. 2007; 120 (5): 1255 - 1261.
27. Spinal problems in mucopolysaccharidosis I (Hurler syndrome) / V. Tandon, J. B. Williamson [et al.]// J. Bone Joint. Surg. Br. 1996 ; 78(6): 938 - 944.
28. The natural history of the severe form of Hunter's syndrome: a study based on 52 cases / I. D Young, P. S. Harper [et al.] // Dev. Med. Child. Neurol. 1983; 25(4): 481 – 489.
29. The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness / A. Nemes, R. G. M. Timmermans, J. H. Wilson [et al.]// Heart Vessels. 2008; 23:108.
30. Upper airways abnormalities and tracheal problems in Morquio’s disease / P. P. Walker, E. Rose [et al.]// Thorax, 2003; 58 :458 - 459.
31. Vasilev F. Mucopolysaccharidosis-Plus Syndrome / F. Vasilev, A. Sukhomyasova, T. Otomo //International Journal of Molecular Sciences. 2020; 21 (2): 421.
32. Vestronidase alfa: a review in mucopolysaccharidosis VII / McCafferty E. H., Scott L. J. // BioDrugs. 2019; 33 (2): 233-240.
33. Wraith J. E. Mucopolysaccharidosis type VI / J. E. Wraith, S. Jones // Pediatr. Endocrinol. Rev. 2014;12: 102 - 106.
Review
For citations:
Novgorodova S.N., Maksimova N.R., Sukhomyasova A.L. Genetics of mucopolysaccharidoses. Yakut Medical Journal. 2022;(2):101-106. https://doi.org/10.25789/YMJ.2022.78.26